John Apathy is a digital transformation leader and Chief Solutions Officer at XponentL Data, focusing on innovation within the Life Sciences industry. With over 35 years of experience, Apathy has held senior roles in data and IT strategy at prominent companies such as Bristol-Myers Squibb, Celgene, and GlaxoSmithKline, leading transformative initiatives to enhance research and development capabilities. A biochemist by training, Apathy possesses deep expertise in the discovery, development, and commercialization of new medicines, complemented by a strong background in management consulting. Apathy currently serves on the Board of Trustees for the Coriell Institute for Medical Research and advises multiple organizations in the Life Sciences sector. Apathy is also pursuing advanced degrees in Biochemistry, Biology/Immunology, and an MBA in Marketing/Strategy.
Location
Philadelphia, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices